Fortis Healthcare Ltd

Fortis Healthcare Ltd

Fortis Healthcare Ltd held its 30th Annual General Meeting (AGM) on August 11, 2026, through video conferencing. The meeting was chaired by Mr. Leo Puri, Chairman of the Company. The company's financial statements for the year ended March 31, 2026, were adopted, and a final dividend of Rs. 1 per equity share was declared. The meeting also approved the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director and CEO for a period of two years.

Fortis Healthcare Ltd

Fortis Healthcare Ltd held its 30th Annual General Meeting (AGM) on August 11, 2026, through video conferencing. The meeting was attended by the Chairman, Directors, and Key Managerial Personnel. The company presented its audited financial statements for the year ended March 31, 2026, and declared a final dividend of Rs. 1 per equity share. The meeting also approved the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director and CEO for a period of two years.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has made a newspaper publication under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the un-audited financial results for the quarter ended June 30, 2026.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has made the audio recording of its Q1FY27 earnings call available on its website, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has released its Q1 FY27 earnings presentation, highlighting a consolidated revenue of ₹2,545 crores, consolidated operating EBITDA of ₹568 crores, and consolidated PBT of ₹354 crores. The company's net debt to EBITDA ratio has improved to 1.01x from 0.92x.

Fortis Healthcare Ltd

Fortis Healthcare Ltd announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with consolidated revenues at INR 2,545 Cr, up 17.5%, and operating EBITDA margin at 22.3%. The company also announced its entry into an Operations and Management agreement for a 300-bedded greenfield multi-specialty hospital in Cuttack, Odisha.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced the appointment of B S R & Co. LLP as its tax auditors for the financial year 2025-26.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, along with the appointment of tax auditors and a limited review report by B S R & Co. LLP.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the appointment of B S R & Co. LLP as tax auditors for the financial year 2025-26.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has informed about the approval of an intra-group restructuring involving the merger of its wholly owned subsidiaries, Agilus Pathlabs Private Limited and DDRC Agilus Pathlabs Limited, into Agilus Diagnostics Limited, subject to the approval of the National Company Law Tribunals (NCLTs) or any other relevant authority.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced the schedule of its upcoming conference call to discuss the unaudited Q1FY27 financial results, to be held on August 07, 2026.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced an upcoming conference call to discuss its unaudited Q1FY27 financial results. The call is scheduled for August 07, 2026, at 11:00 am (IST) and will be held virtually. The company has provided dial-in numbers and a participation link for investors and analysts.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 to consider and approve the Un-audited financial results (standalone & consolidated) for the quarter ended June 30, 2026.

Fortis Healthcare Ltd

Fortis Healthcare Ltd has announced a final dividend of Rs. 1 per equity share for the financial year ended March 31, 2026, subject to shareholder approval at the 30th Annual General Meeting on August 11, 2026. The dividend will be payable after deduction of tax at source (TDS) in accordance with the Income Tax Act, 2025.